✦ LIBER ✦

Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients

✍ Scribed by Hsin-Yun Sun; Marilyn Wagener; Thomas V. Cacciarelli; Nina Singh

Book ID: 115092209
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 102 KB
Volume: 26
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2012.01619.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of pretransplant rifaximin therap

Impact of pretransplant rifaximin therapy on early post-liver transplant infections

✍ Esfeh, Jamak Modaresi; Hanouneh, Ibrahim A.; Koval, Christine E.; Kovacs, Christ 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

The impact of hepatitis C virus infectio

The impact of hepatitis C virus infection on liver disease in renal transplant recipients

✍ Nobumasa Fujimoto; Masahiro Kyo; Yasuji Ichikawa; Takanobu Fukunishi; Shunsuke N 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 370 KB

The Impact of Early Corticosteroid Withd

The Impact of Early Corticosteroid Withdrawal on Graft Survival in Liver Transplant Recipients

✍ H.B. Meadows; D.J. Taber; N.A. Pilch; S.M. Tischer; P.K. Baliga; K.D. Chavin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Impact of immunosuppression on immunopat

Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation

✍ Geoffrey W. McCaughan; Amany Zekry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Question of using valganciclovir for cyt

Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients

✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n ϭ 49) compared with the standard dose of ganciclovir (n ϭ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au

Risk factors for the development of prog

Risk factors for the development of progressive renal dysfunction in post-liver transplant recipients

✍ Liu, Lawrence U.; Rayhill, Stephen C.; Kalil, Roberto; Schmidt, Warren N.; Labre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 497 KB